Back to News
Market Impact: 0.25
Legend Biotech taps Novartis veteran Zhang as CEO
Source: reuters.com
Management & GovernanceHealthcare & BiotechCompany Fundamentals
Legend Biotech appointed longtime Novartis executive Ingrid Zhang as CEO, effective immediately. The leadership change is intended to support expansion beyond Carvykti, the company’s blockbuster cancer therapy, though no financial targets or operational guidance were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
LEGN0.35
NVS0.05
More News
- Grab aims for 'next level' in financial services with purchase of buy-now pay-later platform Atome
- China's AI leaders keep quiet despite U.S. 'publicity' on tech risks
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Karin Rådström is steering Daimler Truck in a new direction as the world’s biggest truckmaker faces a growing challenge from China
- France would back Dutch veteran Knot to lead ECB, wants chief economist job, sources say
- China’s slower loan growth is the new normal, central bank governor says